TrialBMC cardiovascular disorders2020

Efficacy and safety of ambrisentan in Chinese patients with connective tissue disease-pulmonary arterial hypertension: a post-hoc analysis.

Mengtao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.